Still looks like "controlled bleeding" to me. In absence of broker data I strongly assume that underwriters are still slowly and steadily releasing extra shares into the market. The moment this stops and/or more info about Bouldercombe funding are released then it will slowly rise. In fact it has held up remarkably well in the general sell-off lately.
In the meantime this is a bottom drawer investment to me.
Still looks like "controlled bleeding" to me. In absence of...
-
- There are more pages in this discussion • 927 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)